Hercules Capital (HTGC) has agreed to provide NorthStar Medical Technologies with a multi-year growth capital facility of up to $185 million, including a $100 million upfront financing, NorthStar said Tuesday.
NorthStar plans to use the funds for growth and expansion, particularly to invest in isotope production and clinical and commercial drug manufacturing capabilities, among others, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.